Related Experiment Video
Updated: Dec 25, 2025

08:34
Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink
Published on: April 21, 2016
17.2K
Regulating Hybrids: 'Making a Mess' and 'Cleaning Up' in Tissue Engineering and Transpecies Transplantation.
Nik Brown1, Alex Faulkner2, Julie Kent3
11Department of Sociology, Science and Technology Studies Unit, University of York, York, YO10 5DD UK.
Social Theory & Health : STH
|April 1, 2020
Summary
Novel biosciences like human tissue engineering (TE) and xenotransplantation (XT) blur regulatory lines. Current frameworks struggle to manage these hybrid innovations due to their increasing material and practical overlap.
Area of Science:
- Biosciences
- Regulatory Science
- Biotechnology
Background:
- Novel biosciences, particularly hybrid technologies, challenge existing regulatory frameworks.
- Human tissue engineering (TE) and xenotransplantation (XT) are examples of such innovations.
- Regulators have attempted to govern TE and XT separately, creating distinct institutional boundaries.
Purpose of the Study:
- To explore the institutional regulation of novel biosciences.
- To develop a conceptual vocabulary for understanding material and institutional hybrids.
- To compare the regulatory approaches to human tissue engineering and xenotransplantation.
Main Methods:
- Comparative analysis of regulatory frameworks for TE and XT.
- Conceptual analysis of material and institutional hybrids in biosciences.
- Examination of the practical and material overlaps between TE and XT.
Main Results:
- Despite regulatory attempts at separation, TE and XT exhibit significant practical and material interconnectedness.
- Human and animal biological materials and products are more closely linked than institutional boundaries acknowledge.
- This interconnectedness creates instability in the regulation of implants and transplants.
Conclusions:
- Existing regulatory frameworks are ill-equipped to handle the hybrid nature of novel biosciences.
- The "purification" attempts by regulators are challenged by the corporeal realities of TE and XT.
- There is a need for adaptive regulatory strategies that acknowledge and manage the inherent hybridity of these technologies.
More Related Videos
Related Concept Videos
Transgenic Organisms
33.0K
Overview
33.0K
Tissue Transplantation
810
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
810

